Health Discovery Corporation, Quest Diagnostics, Smart Personalized deal

The parties will develop pharmacogenetic tests for breast cancer. Quest will receive a co-exclusive license to Smart Personalized Medicine's breast cancer database, including biopsies and clinical and genomic data on breast cancer patients. Health Discovery will provide its vector machine technology and other IP to develop and/or validate the products. ...